Fox Rothschild LLP are most popular:
- within Immigration and Corporate/Commercial Law topic(s)
- with Finance and Tax Executives
- with readers working within the Automotive, Basic Industries and Healthcare industries
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Forest Laboratories, LLC, et al. v. Apotex Corp., et al., Civil Action No. 15-018-GMS (D.Del., November 8, 2016) (consolidated), the Court rendered its Markman opinion construing seven (7) disputed terms in U.S. Patent Nos. 6,417,175 ("the '175 patent") and 8,247,400 ("the '400 patent"). The patents-in-suit relate to new cephem compounds useful for the treatment of bacterial infections and pharmaceutical compositions containing the compounds.
A copy of the Memorandum Opinion is attached.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
